• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

adagiomedical

Adagio Medical wins FDA breakthrough nod for cryoablation tech

April 17, 2025 By Sean Whooley

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation system. The Laguna Hills, California–based company based its vCLAS cryoablation catheter on its proprietary ultra-low cryoablation technology (ULCT). It aims to address the challenges of ventricular tachycardia (VT) ablations, comprising part of the Adagio VT cryoablation system. The system’s […]

Filed Under: Cardiovascular, Catheters, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: adagiomedical, FDA

Adagio Medical to restructure, reduce workforce

February 28, 2025 By Sean Whooley

Adagio Medical (Nasdaq:ADGM) announced today that it plans a corporate restructuring and realignment of resources. The Laguna Hills, California–based company, which develops catheter ablation technologies for treating cardiac arrhythmias, wants to prioritize its FULCRUM-VT pivotal FDA investigational device exemption (IDE) clinical trial activities and its new product design optimization program. “After a comprehensive strategic review, […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Pulsed-Field Ablation (PFA), Vascular Tagged With: adagiomedical

Adagio Medical picks medtech veteran Todd Usen as new CEO

December 16, 2024 By Sean Whooley

Adagio Medical (Nasdaq:ADGM) announced today that it appointed Todd Usen as its new CEO and board director. Usen’s appointment follows the departure of Olav Bergheim, the company’s founder, CEO and board chair, effective Dec. 13. The company concurrently made Usen CEO and Orly Mishan chair of the board of directors. Bergheim intends to continue serving […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Pulsed-Field Ablation (PFA) Tagged With: adagiomedical, Personnel Moves

Adagio has first case in IDE study for cryoablation tech

October 24, 2024 By Sean Whooley

Adagio Medical (Nasdaq:ADGM) today announced the first completed procedure in an FDA IDE study of its VT cryoablation system. The company picked up FDA investigational device exemption (IDE) for the study of its VT cryoablation system in May. Laguna Hills, California-based Adagio also reported the first commercial procedures in Europe following CE mark approval at […]

Filed Under: Cardiovascular, Clinical Trials, Pulsed-Field Ablation (PFA) Tagged With: adagiomedical

Adagio Medical goes public in SPAC merger

August 2, 2024 By Sean Whooley

Adagio Medical announced that it completed its previously announced business combination with Arya Sciences Acquisition Corp IV. Arya, a special purpose acquisition company (SPAC), agreed to acquire Adagio in February. The acquisition takes Adagio public, trading under the “ADGM” ticker on the Nasdaq market as of yesterday, Aug. 1. Adagio continues operations under its current […]

Filed Under: Business/Financial News, Cardiovascular, Mergers & Acquisitions, Pulsed-Field Ablation (PFA), Wall Street Beat Tagged With: adagiomedical

Adagio Medical wins FDA IDE for cryoablation study, completes first commercial cases in Europe

May 17, 2024 By Sean Whooley

Adagio Medical announced today that it picked up FDA investigational device exemption (IDE) for a study of its VT cryoablation system. The Laguna Hills, California-based company also completed the first commercial procedures in Europe following CE mark approval. Adagio Medical designed its VT system with the vCLAS cryoablation catheter based on its proprietary ultra-low cryoablation […]

Filed Under: Cardiovascular, Catheters, Clinical Trials Tagged With: adagiomedical, HRS 2024

Ablation tech developer Adagio Medical to go public in SPAC deal

February 15, 2024 By Sean Whooley

Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public. Upon the closing of the transaction, Adagio is set to become a subsidiary of Aja Holdco, still operating under its existing management team and under the name “Adagio Medical.” Arya expects to list the combined company’s […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Mergers & Acquisitions, Pulsed-Field Ablation (PFA), Wall Street Beat Tagged With: adagiomedical

Adagio Medical starts iCLAS AFib trial

December 18, 2019 By Sean Whooley

Adagio Medical announced that it enrolled the first patient in its iCLAS investigational device exemption clinical trial for assessing the treatment for persistent atrial fibrillation. The iCLAS is a low-temperature intelligent continuous legion ablation system. The FDA-approved study has the goal of evaluating the safety and efficacy of the system in PsAF to support pre-market approval […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Food & Drug Administration (FDA) Tagged With: adagiomedical

FDA OKs Adagio Medical’s cryoablation afib trial

August 20, 2019 By Sean Whooley

Adagio Medical yesterday said it received an investigational device exemption from the FDA for a clinical trial of its cryoablation device for treating atrial fibrillation. The 80-patient study, a non-randomized, single-arm trial of subjects with persistent afib, will use the Laguna Hills, Calif.-based company’s intelligent continuous lesion ablation system to treat patients with afib of […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Food & Drug Administration (FDA) Tagged With: adagiomedical

Adagio Medical raises $7m

March 13, 2019 By Fink Densford

Cardiovascular cryoablation tech developer Adagio Medical has raised approximately $7 million in a new round of equity and options financing, according to a recently posted SEC filing. The company is looking to raise an additional $13 million, which would bring the total raised up to $20 million, according to the filing. Adagio Medical is developing and producing […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: adagiomedical

Adagio Medical launches OneShot+ cardio cryoablation cath

October 2, 2018 By Fink Densford

Cardiovascular cryoablation tech developer Adagio Medical said it launched its One Shot+ cryoablation catheter, and that the first patient has been treated with the device. The Laguna Hills, Calif.-based company said the newly cleared One Shot+ catheter is intended for pulmonary vein isolation and other continuous ablation lesions of non-pulmonary-vein targets for treating atrial fibrillation. […]

Filed Under: Business/Financial News, Cardiovascular, Catheters Tagged With: adagiomedical

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy